+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Digital Biomanufacturing Market by Product Type (Cell Therapy, Monoclonal Antibodies, Recombinant Proteins), Process Stage (Continuous Biomanufacturing, Downstream Processing, Upstream Processing), Technology, End User, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5925083
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Digital Biomanufacturing Market grew from USD 18.97 billion in 2024 to USD 20.90 billion in 2025. It is expected to continue growing at a CAGR of 9.75%, reaching USD 33.16 billion by 2030.

How Digital Biomanufacturing Innovations Are Pioneering a New Era in Bioprocessing to Deliver Enhanced Productivity and Accelerated Therapeutic Development

Digital biomanufacturing stands at the crossroads of innovation and operational transformation, offering unprecedented potential to reshape how therapeutic molecules are produced. As industry stakeholders confront escalating demand for biologics and personalized therapies, the integration of digital tools-ranging from advanced analytics to automation-has become a catalyst for redefining production paradigms. Initially, this wave of change centers on the convergence of data connectivity and real-time process control, fostering transparency and agility across development pipelines.

Moreover, the digital era empowers manufacturers to reduce cycle times and enhance quality assurance by leveraging predictive modeling and machine learning. These capabilities not only streamline scaling efforts but also mitigate risks associated with batch variability and supply chain disruptions. Furthermore, the seamless interplay between digital twins and process simulation supports continuous improvement initiatives, underpinning a proactive stance toward risk management.

Ultimately, the introduction of digital biomanufacturing heralds a transformative journey, wherein agility, scalability, and regulatory compliance converge. By embracing this evolution, organizations can accelerate the path from bench to bedside, unlocking new frontiers in patient-centric care.

Transformative Shifts Define the Next Frontier in Digital Biomanufacturing as Automation, AI-Driven Insights, and Modular Platforms Reshape Production Landscapes

The biomanufacturing landscape is undergoing fundamental shifts driven by the confluence of automation, artificial intelligence, and modular processing platforms. As organizations prioritize agility and cost efficiency, automated workflows have emerged as a cornerstone for reducing manual interventions and enhancing reproducibility. In parallel, AI-driven algorithms generate real-time insights into process performance, enabling predictive maintenance and adaptive control strategies that preempt deviations.

Concurrently, modular processing units offer flexible assembly and rapid reconfiguration, facilitating multi-product facilities that can pivot swiftly in response to therapeutic demand. These modular approaches reduce capital expenditure cycles and allow for phased capacity expansion, aligning production footprints with market dynamics. In addition, cloud-based data management architectures are granting remote access to process metrics, unlocking new avenues for collaborative development and decentralized decision-making.

Together, these transformative shifts are charting a new frontier in biomanufacturing, where digital integration serves as a bedrock for operational excellence, strategic resilience, and long-term growth.

Assessing the Implications of United States Tariff Adjustments for 2025 on Supply Chain Dynamics, Raw Material Accessibility, and Global Biomanufacturing Competitiveness

The recent adjustments to United States tariff policies slated for 2025 carry far-reaching implications for the global biomanufacturing supply chain. Alterations in import duties on critical raw materials and single-use components can create pressure points that ripple through upstream and downstream operations. For instance, heightened tariffs may raise the cost of sensors, bags, and connectors, prompting manufacturers to reevaluate sourcing strategies and inventory management practices.

In response, companies are intensifying efforts to localize supply sources and establish strategic alliances with domestic suppliers to mitigate exposure to trade policy fluctuations. Simultaneously, firms are exploring alternative materials and process intensification techniques that reduce dependency on tariff-affected imports. Furthermore, the evolving tariff landscape underscores the importance of proactive regulatory intelligence and scenario planning to preserve cost structures and maintain production continuity.

By anticipating tariff-driven shifts, biomanufacturers can recalibrate procurement frameworks, fortify supply chain resilience, and safeguard production timetables against unforeseen disruptions.

Unveiling Key Market Segmentation Insights That Illuminate How Product Type, Process Stage, Technology Adoption, End User Profiles, and Application Needs Drive Strategic Decisions

A nuanced understanding of market segmentation reveals critical pathways for strategic investment and innovation. Product type segmentation highlights the prominence of cell therapy, monoclonal antibodies, recombinant proteins, and vaccines, with cell therapy further distinguished by CAR-T therapy, stem cell therapy, and tissue engineering. Each category presents distinct process requirements and regulatory considerations, informing tailored bioprocessing configurations.

Process stage segmentation delineates upstream processing, downstream processing, and continuous biomanufacturing as key milestones. Within upstream workflows, bioreactors, cell culture, and media development drive cell proliferation efficiencies. Downstream processes leverage chromatography and filtration to ensure product purity, while continuous biomanufacturing harmonizes upstream and downstream operations into an uninterrupted flow, subdivided into continuous upstream and continuous downstream phases.

Technology segmentation contrasts single-use systems and traditional systems. Single-use platforms, comprising bags, connectors, and sensors, enable rapid deployment and reduced cross-contamination risk, whereas traditional clean-in-place systems and stainless-steel bioreactors offer robustness and long-term cost amortization. These technological choices influence facility design and operational flexibility.

End user segmentation spans academic organizations, biopharmaceutical companies, contract development and manufacturing organizations, and research institutes. Within academic settings, government research labs and universities spearhead early-stage innovation and translational research. This dynamic drives industry-academia collaboration, fostering novel process intensification and technology validation.

Finally, application segmentation encompasses diagnostics, industrial enzymes, and therapeutics. Diagnostic workflows, including imaging and in vitro testing, demand precision and scalability. Industrial enzyme applications prioritize cost-effective production, while therapeutic manufacturing emphasizes stringent quality controls and regulatory compliance. Collectively, these segmentation insights guide capital allocation, capacity planning, and partnership strategies.

Mapping Regional Variations to Understand How the Americas, Europe Middle East & Africa, and Asia-Pacific Are Shaping Unique Biomanufacturing Growth Trajectories

Regional variations in market maturity, regulatory frameworks, and infrastructure capacity are pivotal in shaping growth trajectories across the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, robust biopharmaceutical pipelines and advanced manufacturing networks underpin rapid adoption of digital technologies, driven by strong venture capital support and collaborative innovation hubs. This environment encourages early implementation of automation and predictive analytics.

Within Europe, Middle East & Africa, regulatory harmonization efforts and public-private partnerships are accelerating modernization initiatives. Diverse market conditions require adaptable digital solutions that comply with evolving standards across multiple jurisdictions. As a result, modular facility designs and cloud-enabled data platforms are gaining traction to support cross-border collaborations and supply chain visibility.

The Asia-Pacific region exhibits high growth potential, fueled by increasing biopharma investments and capacity expansions in key economies. Local manufacturing incentives and government initiatives promote technology transfer and indigenous innovation, fostering scalable digital ecosystems. This regional dynamic emphasizes cost efficiencies, making single-use systems and continuous processing models particularly attractive for emerging markets.

Collectively, these regional insights inform strategic prioritization, ensuring that digital biomanufacturing investments align with localized opportunities and regulatory landscapes.

Analyzing Leading Corporate Strategies in Digital Biomanufacturing to Highlight Innovation Leadership, Strategic Partnerships, and Operational Excellence Across the Ecosystem

Leading organizations are deploying diverse strategies to secure competitive advantage within digital biomanufacturing. Strategic partnerships between technology providers and contract development organizations are fostering integrated service offerings that streamline process transfer and scale-up activities. Concurrently, in-house R&D investments are focusing on data analytics platforms that correlate process parameters with product quality attributes, reinforcing quality-by-design principles.

Operational excellence programs are advancing through the implementation of digital twin models, enabling virtual process optimization and risk mitigation. Companies with global footprints are harmonizing data standards across multiple sites, ensuring consistent performance metrics and facilitating remote monitoring capabilities. In parallel, talent development initiatives are cultivating cross-functional teams with expertise in bioprocessing, data science, and regulatory affairs.

Furthermore, acquisitions and joint ventures are expanding service portfolios, integrating complementary capabilities in automation, software development, and facility engineering. These corporate maneuvers are accelerating market entry and enhancing end-to-end solution offerings, ultimately driving enhanced value for stakeholders across the biomanufacturing ecosystem.

Actionable Recommendations for Industry Leaders to Accelerate Digital Biomanufacturing Transformation Through Collaborative Models, Scalable Infrastructure, and Proactive Talent Development

Industry leaders should prioritize the establishment of collaborative networks that unite bioprocess experts, data scientists, and technology partners. By fostering shared innovation environments, organizations can co-develop modular systems and standardized data infrastructures that accelerate technology validation and adoption. Investing in scalable infrastructure that supports both single-use and traditional processing modalities will enable flexible capacity alignment with evolving product pipelines.

In addition, cultivating digital proficiency through targeted training initiatives ensures that cross-disciplinary teams can harness advanced analytics and automation tools effectively. Proactive talent development programs should emphasize hands-on experience with predictive modeling, continuous processing, and hybrid manufacturing approaches. Furthermore, embedding continuous improvement mindsets into organizational culture will facilitate iterative enhancements and rapid response to market shifts.

Lastly, leaders must adopt a forward-looking regulatory engagement strategy, collaborating with authorities to co-define best practices for digital biomanufacturing. This proactive approach will streamline compliance efforts and foster a conducive environment for innovation, ultimately driving sustainable growth.

Comprehensive Research Methodology Detailing Data Collection, Analytical Frameworks, and Validation Processes for Ensuring Rigorous Biomanufacturing Market Insights

The research methodology underpinning this analysis integrates a blend of primary interviews, extensive secondary literature reviews, and robust data validation processes. Primary inputs were collected through in-depth discussions with senior executives, process engineers, and regulatory specialists across diverse biomanufacturing organizations. These qualitative insights were triangulated with published reports, peer-reviewed journals, and regulatory filings to ensure contextual accuracy.

Simultaneously, secondary research encompassed comprehensive surveys of industry vendors, technology providers, and end-user deployments. Rigorous data cleansing and normalization techniques were applied to reconcile variations in terminology and reporting standards. Key performance metrics and case study outcomes were mapped against process configurations to identify reproducible success factors.

Furthermore, an iterative validation framework engaged subject matter experts to review preliminary findings and offer critical feedback. This multi-stage review process fortified analytical rigor and ensured alignment with real-world operational conditions. Collectively, these methodological components deliver a high level of confidence in the insights presented.

Synthesizing Key Executive Takeaways to Capture the Critical Insights and Strategic Imperatives Driving Progress in Digital Biomanufacturing

The synthesis of these executive perspectives underscores the pivotal role of digital integration in shaping the future of biomanufacturing. From emerging automation strategies to tariff-driven supply chain adaptations, organizations must navigate a complex landscape marked by rapid technological advancement and evolving regulatory directives. Strategic segmentation analysis reveals that tailored approaches to product type, process stage, technology selection, end user engagement, and application focus are critical for sustained competitiveness.

Regional insights further highlight the need to align investments with local market dynamics and regulatory frameworks, ensuring that digital transformation initiatives are both contextually relevant and operationally viable. Concurrently, corporate strategies centered on innovation partnerships, data harmonization, and talent cultivation are proving instrumental in driving measurable improvements in efficiency and product quality.

Ultimately, by embracing the actionable recommendations detailed herein and leveraging validated research methodologies, decision-makers can chart a clear path toward operational excellence and long-term growth within the digital biomanufacturing ecosystem.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Cell Therapy
      • Car-T Therapy
      • Stem Cell Therapy
      • Tissue Engineering
    • Monoclonal Antibodies
    • Recombinant Proteins
    • Vaccines
  • Process Stage
    • Continuous Biomanufacturing
      • Continuous Downstream
      • Continuous Upstream
    • Downstream Processing
      • Chromatography
      • Filtration
    • Upstream Processing
      • Bioreactors
      • Cell Culture
      • Media
  • Technology
    • Single-Use Systems
      • Bags
      • Connectors
      • Sensors
    • Traditional Systems
      • Clean-In-Place Systems
      • Stainless-Steel Bioreactors
  • End User
    • Academic Organizations
      • Government Research Labs
      • Universities
    • Biopharmaceutical Companies
    • Contract Development And Manufacturing Organizations
    • Research Institutes
  • Application
    • Diagnostics
      • Imaging
      • In Vitro Testing
    • Industrial Enzymes
    • Therapeutics
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Thermo Fisher Scientific Inc.
  • Sartorius AG
  • Merck KGaA
  • Danaher Corporation
  • Eppendorf AG
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer, Inc.
  • Shimadzu Corporation
  • Rockwell Automation, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Implementation of AI-powered process analytical technology to enhance real-time quality control in biomanufacturing lines
5.2. Adoption of digital twin simulations for predictive scale-up of cell culture and fermentation workflows in bioproduction facilities
5.3. Deployment of cloud-native platforms integrating multiomics data for adaptive monitoring of biologic drug manufacturing performance
5.4. Utilization of edge computing and IoT-enabled bioreactors for remote monitoring and automated control of continuous bioprocessing
5.5. Integration of blockchain and secure data provenance systems to ensure traceability and compliance across digital biomanufacturing supply chains
5.6. Application of machine learning algorithms for predictive maintenance and downtime reduction in large-scale biologics production equipment
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Digital Biomanufacturing Market, by Product Type
8.1. Introduction
8.2. Cell Therapy
8.2.1. Car-T Therapy
8.2.2. Stem Cell Therapy
8.2.3. Tissue Engineering
8.3. Monoclonal Antibodies
8.4. Recombinant Proteins
8.5. Vaccines
9. Digital Biomanufacturing Market, by Process Stage
9.1. Introduction
9.2. Continuous Biomanufacturing
9.2.1. Continuous Downstream
9.2.2. Continuous Upstream
9.3. Downstream Processing
9.3.1. Chromatography
9.3.2. Filtration
9.4. Upstream Processing
9.4.1. Bioreactors
9.4.2. Cell Culture
9.4.3. Media
10. Digital Biomanufacturing Market, by Technology
10.1. Introduction
10.2. Single-Use Systems
10.2.1. Bags
10.2.2. Connectors
10.2.3. Sensors
10.3. Traditional Systems
10.3.1. Clean-In-Place Systems
10.3.2. Stainless-Steel Bioreactors
11. Digital Biomanufacturing Market, by End User
11.1. Introduction
11.2. Academic Organizations
11.2.1. Government Research Labs
11.2.2. Universities
11.3. Biopharmaceutical Companies
11.4. Contract Development And Manufacturing Organizations
11.5. Research Institutes
12. Digital Biomanufacturing Market, by Application
12.1. Introduction
12.2. Diagnostics
12.2.1. Imaging
12.2.2. In Vitro Testing
12.3. Industrial Enzymes
12.4. Therapeutics
13. Americas Digital Biomanufacturing Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Digital Biomanufacturing Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Digital Biomanufacturing Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. Sartorius AG
16.3.3. Merck KGaA
16.3.4. Danaher Corporation
16.3.5. Eppendorf AG
16.3.6. Agilent Technologies, Inc.
16.3.7. Bio-Rad Laboratories, Inc.
16.3.8. PerkinElmer, Inc.
16.3.9. Shimadzu Corporation
16.3.10. Rockwell Automation, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. DIGITAL BIOMANUFACTURING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. DIGITAL BIOMANUFACTURING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. DIGITAL BIOMANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. DIGITAL BIOMANUFACTURING MARKET: RESEARCHAI
FIGURE 26. DIGITAL BIOMANUFACTURING MARKET: RESEARCHSTATISTICS
FIGURE 27. DIGITAL BIOMANUFACTURING MARKET: RESEARCHCONTACTS
FIGURE 28. DIGITAL BIOMANUFACTURING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. DIGITAL BIOMANUFACTURING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CAR-T THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CAR-T THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY STEM CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY STEM CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS DOWNSTREAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS DOWNSTREAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS UPSTREAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS UPSTREAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY FILTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY FILTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY BIOREACTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL CULTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL CULTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY MEDIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY MEDIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY BAGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY BAGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONNECTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONNECTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY SENSORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY SENSORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CLEAN-IN-PLACE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CLEAN-IN-PLACE SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY STAINLESS-STEEL BIOREACTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY STAINLESS-STEEL BIOREACTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY GOVERNMENT RESEARCH LABS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY GOVERNMENT RESEARCH LABS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY UNIVERSITIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY IN VITRO TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY IN VITRO TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY INDUSTRIAL ENZYMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY INDUSTRIAL ENZYMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 161. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 162. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 163. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 164. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 165. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2024 (USD MILLION)
TABLE 166. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2025-2030 (USD MILLION)
TABLE 167. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2018-2024 (USD MILLION)
TABLE 168. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2025-2030 (USD MILLION)
TABLE 169. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 170. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 171. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 172. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 173. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 174. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 175. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2024 (USD MILLION)
TABLE 176. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2025-2030 (USD MILLION)
TABLE 177. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, 2018-2024 (USD MILLION)
TABLE 178. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, 2025-2030 (USD MILLION)
TABLE 179. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 182. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 183. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 186. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 187. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 188. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 189. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 190. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 191. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2024 (USD MILLION)
TABLE 192. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2025-2030 (USD MILLION)
TABLE 193. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2018-2024 (USD MILLION)
TABLE 194. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2025-2030 (USD MILLION)
TABLE 195. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 196. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 197. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 198. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 199. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 200. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 201. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2024 (USD MILLION)
TABLE 202. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2025-2030 (USD MILLION)
TABLE 203. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, 2018-2024 (USD MILLION)
TABLE 204. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, 2025-2030 (USD MILLION)
TABLE 205. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 208. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 209. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 212. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 261. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, 2025-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 296. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2024 (USD MILLION)
TABLE 298. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2025-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2018-2024 (USD MILLION)
TABLE 300. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOMANUFACTURING, 2025-2030 (USD MILLION)
TABLE 301. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 302. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 303. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 304. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 305. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 306. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 307. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2024 (USD MILLION)
TABLE 308. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2025-2030 (USD MILLION)
TABLE 309. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY TRADITIONAL SYSTEMS, 2018-2024 (USD MILLION)
TABLE 310. UNITED KINGDOM D

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Digital Biomanufacturing market report include:
  • Thermo Fisher Scientific Inc.
  • Sartorius AG
  • Merck KGaA
  • Danaher Corporation
  • Eppendorf AG
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer, Inc.
  • Shimadzu Corporation
  • Rockwell Automation, Inc.

Table Information